Disparity in Market Prices for Hepatitis C Virus Direct-Acting Drugs

Hdl Handle:
http://hdl.handle.net/10144/582463
Title:
Disparity in Market Prices for Hepatitis C Virus Direct-Acting Drugs
Authors:
Andrieux-Meyer, Isabelle; Cohn, Jennifer; de Araújo, Evaldo S Affonso; Hamid, Saeed S
Journal:
The Lancet. Global Health
Publisher:
Elsevier
Issue Date:
Nov-2015
URI:
http://hdl.handle.net/10144/582463
DOI:
10.1016/S2214-109X(15)00156-4
PubMed ID:
26475012
Language:
en
ISSN:
2214-109X
Appears in Collections:
Health Politics

Full metadata record

DC FieldValue Language
dc.contributor.authorAndrieux-Meyer, Isabelleen
dc.contributor.authorCohn, Jenniferen
dc.contributor.authorde Araújo, Evaldo S Affonsoen
dc.contributor.authorHamid, Saeed Sen
dc.date.accessioned2015-11-22T08:56:09Zen
dc.date.available2015-11-22T08:56:09Zen
dc.date.issued2015-11en
dc.identifier.citationDisparity in market prices for hepatitis C virus direct-acting drugs. 2015, 3 (11):e676-7 Lancet Glob Healthen
dc.identifier.issn2214-109Xen
dc.identifier.pmid26475012en
dc.identifier.doi10.1016/S2214-109X(15)00156-4en
dc.identifier.urihttp://hdl.handle.net/10144/582463en
dc.language.isoenen
dc.publisherElsevieren
dc.rightsArchived with thanks to The Lancet Global Healthen
dc.titleDisparity in Market Prices for Hepatitis C Virus Direct-Acting Drugsen
dc.identifier.journalThe Lancet. Global Healthen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.